Eiger BiopharmaceuticalsEIGRQ
13F holders, Q1 2024 (March 31)24holders
1famous investor
$4.78avg. 13F price*
At the end of Q1 2024, 24 institutions reported holding Eiger Biopharmaceuticals Inc. (EIGRQ) in their 13F filings. The largest holders were Ameriprise Financial Inc. ($1.3M), Propel Bio Management, LLC ($732K) and Simplify Asset Management Inc. ($450K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Eiger Biopharmaceuticals Inc.
- CUSIP
- 28249U204
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $620K |
| Exits | 0 | $0 |
Ownership 24 holders
| Ameriprise Financial Inc. | 0.00% | Add +2.9% | 250,178 | $1.3M |
| Propel Bio Management, LLC | 0.43% | Add +2.9% | 146,381 | $732K |
| Simplify Asset Management Inc. | 0.04% | New | 90,000 | $450K |
| Accretive Wealth Partners, LLC | 0.08% | New | 63,150 | $170K |
| 683 Capital Management, LLC | 0.02% | Reduce -56.4% | 29,660 | $148K |
| Vanguard Group Inc. | 0.00% | Reduce -52.2% | 28,201 | $141K |
| BlackRock Inc. | 0.00% | Add +1.0% | 19,109 | $96K |
| Geode Capital Management, LLC | 0.00% | Add +2.8% | 12,652 | $63K |
| Renaissance Technologies | 0.00% | Reduce -0.5% | 11,102 | $56K |
| RBF Capital, LLC | 0.00% | No change | 10,971 | $55K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +228.9% | 1,948 | $10K |
| Bank of America Corp. | 0.00% | Reduce -24.7% | 1,174 | $6K |
| Acadian Asset Management LLC | 0.00% | Reduce -81.1% | 1,064 | $5K |
| Royal Bank of Canada | 0.00% | Add +720.3% | 362 | $2K |
| Morgan Stanley | 0.00% | Reduce -18.2% | 366 | $2K |
| Osaic Holdings, Inc. | 0.00% | Add +31.8% | 331 | $2K |
| BNP Paribas Financial Markets | 0.00% | No change | 94 | $470 |
| National Bank of Canada | 0.00% | Reduce -1.1% | 41 | $93 |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +0.1% | 12 | $60 |
| Toth Financial Advisory Corp. | 0.00% | New | 11 | $56 |
| Wells Fargo & Company | 0.00% | Add +0.5% | 10 | $50 |
| UBS Group AG | 0.00% | Reduce -97.5% | 9 | $45 |
| JPMorgan Chase & Co. | 0.00% | Reduce -7.0% | 5 | $25 |
| Citigroup Inc. | 0.00% | Reduce -95.8% | 4 | $20 |
"% of holder's portfolio" is EIGRQ's weight in each manager's 13F, not the share of Eiger Biopharmaceuticals Inc. the manager owns.